ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

UT System Launches Probe of Submission Of Controversial MD Anderson Grant

June 8, 2012

Government Shutdown Cancels NCI Site Visit To Mayo Cancer Center

October 11, 2013

AACR Supports Bypass Budget; Public Consortium Sequences Mouse Genome

May 10, 2002

NCAB Working Group Appointed To Review NCI Progress

April 30, 2010

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003

DeVita, Greenwald Assure Centers They’ll Get More Money for Cancer Control

May 11, 1984